Korro Bio (KRRO) Receivables - Other (2018 - 2020)

Korro Bio (KRRO) has reported Receivables - Other for 3 consecutive years, with $246000.0 the latest figure, recorded in Q1 2020.

• For the quarter ending Q1 2020, Receivables - Other changed N/A year-over-year to $246000.0; the trailing twelve-month figure through Mar 2020 stood at $246000.0 (changed N/A YoY), and the FY2019 full-year result was $805000.0, up 400.0% from the prior year.
• Receivables - Other retreated to $246000.0 in Q1 2020 per KRRO's latest filing, from $805000.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $805000.0 in Q4 2019 and bottomed at $161000.0 in Q4 2018.
• Historically, Receivables - Other has averaged $405000.0 across 3 years, with a median of $327000.0 in 2019.
• The widest YoY moves for Receivables - Other: up 400.0% in 2019, down 400.0% in 2019.
• Over 3 years, Receivables - Other stood at $161000.0 in 2018, then surged by 400.0% to $805000.0 in 2019, then slumped by 69.44% to $246000.0 in 2020.
• According to Business Quant data, Receivables - Other over the past three periods registered $246000.0, $805000.0, and $408000.0 for Q1 2020, Q4 2019, and Q3 2019 respectively.